O'Dell Group, LLC Neogenomics Inc Transaction History

O'Dell Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$11.67 - $20.73 $20,422 - $36,277	1,750 New	1,750 $28,000
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $24,675 - $34,702	1,750 New	1,750 $28,000
Q3 2022 Nov 08, 2022	SELL	$7.86 - $12.91 $5,895 - $9,682	-750 Reduced 30.0%	1,750 $15,000
Q2 2022 Aug 11, 2022	SELL	$7.06 - $13.97 $9,319 - $18,440	-1,320 Reduced 34.55%	2,500 $20,000
Q3 2021 Nov 15, 2021	BUY	$41.66 - $52.52 $159,141 - $200,626	3,820 New	3,820 $184,000
Q1 2021 Apr 29, 2021	SELL	$41.56 - $59.88 $158,759 - $228,741	-3,820 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$36.08 - $56.47 $137,825 - $215,715	3,820 New	3,820 $206,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of O'Dell Group, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Dell Group, LLC with notifications on news.